Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- Check6 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has been replaced with a 403 Forbidden error page, effectively blocking access to the study record details. Visible additions include a 403 header and related HTML, signaling an access restriction rather than new study information.SummaryDifference19%

- Check49 days agoChange DetectedAdded a note showing the 2019 ( U.S. NIH Grant/Contract ) in the study identifiers, and updated the page version to v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag in the page footer updated from v3.6.4 to v3.6.5, indicating a minor system update. This change does not affect the study details or other user-facing information.SummaryDifference0.0%

- Check84 days agoChange DetectedThe additions show a new revision tag, Revision: v3.6.4, and the deletions remove the previous tag Revision: v3.6.3. This indicates a new deployment of the page; the change is technical rather than content-related.SummaryDifference0.0%

- Check106 days agoChange Detected- Revision label updated from v3.6.2 to v3.6.3 on the page. This indicates a minor update to the study page content display.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.